Sign inJoin waitlistJoin the waitlist

Betul Hatipoglu

Director, Diabetes Center, UH Cleveland Medical Center · Case Western Reserve University/University Hospitals Cleveland Medical Center

Credentials: · · · ·

History

Diabetes Center · Case Western Reserve University/University Hospitals Cleveland Medical Center
Present
Clinical and Molecular Endocrinology Division · Case Western Reserve University/University Hospitals Cleveland Medical Center
Present
Case Center for Diabetes · Case Western Reserve University
Present

Endocrinology, Diabetes, and Metabolism
University of Illinois College of Medicine at Chicago
1997–1999
Michael Reese Hospital And Medical Center
1993–1996
ISTANBUL UNIV, ISTANBUL TIP FAK, ISTANBUL, TURKEY
1988–1992

Research

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
New England Journal of Medicine · 2022 · 158 citations
Islet transplantation for brittle type 1 diabetes: the UIC protocol
American Journal of Transplantation · 2008 · 131 citations
Improved quality of life following total pancreatectomy and auto-islet transplantation for chronic pancreatitis
Journal of Gastrointestinal Surgery · 2012 · Last of 9 authors · 81 citations

Amir Hamrahian
14 papers
Matthew Walsh
13 papers
RW
Robert Weil
12 papers
Tyler Stevens
11 papers
AK
Allan Kennedy
9 papers
CF
Charles Faiman
9 papers
JO
Jose Oberholzer
9 papers · 1 as a fellow
KA
Khawla Ali
8 papers
Enrico Benedetti
6 papers
Julia Blanchette
6 papers
KP
Kevin Pantalone
6 papers · 1 as a fellow
Timothy Gardner
5 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $1.2K · University of Illinois at Chicago
2004–2005

Clinical trials

The Impact of Combined Mindfulness-Based Interventions and Nutritional Counseling on Physician Burnout
Principal investigator · Completed
The Cleveland Clinic
2019–2020
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT
Principal investigator · Completed · Phase 2
The Cleveland Clinic
2017–2020
Diabetes: Functional Medicine Approach Vs. Usual Care
Principal investigator · Completed
Keren Zhou
2017–2025
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Site PI · Recruiting · Phase 1, Phase 2
COUR Pharmaceutical Development Company, Inc.
2025–2027